PharmaCyte Biotech (PMCB) Earnings Date, Estimates & Call Transcripts → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free PMCB Stock Alerts $2.14 0.00 (0.00%) (As of 05/24/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJul. 29EstimatedActual EPS (Mar. 18) -$0.65 Missed By -$0.65 Get PharmaCyte Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for PMCB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePMCB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PMCB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIThree basic steps to building the Ultimate Dividend Portfolio.There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). PMCB Earnings Date and InformationPharmaCyte Biotech last announced its earnings data on March 18th, 2024. The reported ($0.65) earnings per share (EPS) for the quarter. PharmaCyte Biotech has generated ($1.20) earnings per share over the last year (($1.20) diluted earnings per share). PharmaCyte Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off prior year's report dates.Read More PharmaCyte Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/29/2024(Estimated)------- 3/18/2024Q3 2024-($0.65)($0.65)($0.65)--12/15/2023Q2 2024-($0.64)($0.64)($1.02)--9/18/2023Q1 2024-($0.28)($0.28)($0.28)--7/31/2023Q4 2023-($0.01)($0.01)($0.01)--3/16/2023Q3 2023-($0.04)($0.04)($0.04)--12/14/2022Q2 2023-($0.09)($0.09)($0.09)-- Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 9/14/2022Q1 2023($0.07)($0.07)-($0.07)--7/28/2022Q4 2022-($0.06)($0.06)($0.06)--3/15/2022Q3 2022($0.05)($0.04)+$0.01($0.04)--12/15/2021Q2($0.07)($0.06)+$0.01($0.06)--9/14/2021Q1 2022-($0.64)($0.64)($0.64)-- PharmaCyte Biotech Earnings - Frequently Asked Questions When is PharmaCyte Biotech's earnings date? PharmaCyte Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off last year's report dates. Learn more on PMCB's earnings history. How much profit does PharmaCyte Biotech generate each year? PharmaCyte Biotech (NASDAQ:PMCB) has a recorded net income of -$4.32 million. PMCB has generated -$1.20 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Senti Biosciences Earnings Results Aptose Biosciences Earnings Results Evaxion Biotech A/S Earnings Results AIM ImmunoTech Earnings Results Coeptis Therapeutics Earnings Results Inhibikase Therapeutics Earnings Results BioCardia Earnings Results Organovo Earnings Results Sorrento Therapeutics Earnings Results Scinai Immunotherapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:PMCB) was last updated on 5/24/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryWrite this ticker symbol down…StocksToTrade$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyNvidia’s Quiet $1 Trillion PivotWeiss RatingsA personal note from Behind The Markets' CEO Dylan Jovine...Behind the MarketsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.